NCT05241964

Platelet-rich Plasma(PRP) Injection in ED

A Prospective Trial of Autologous Platelet-rich Plasma Injection in Erectile Dysfunction Treatment

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: National Taiwan University Hospital · Academic / Other
• Sex: Male
• Age: 20 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

RPR contains rich-in growth factors and has the properties of helping tissue regeneration and nerve repair. In theory, it is possibility of curing ED.

Detailed description

There are many reasons of erectile dysfunction(ED). If left untreated, there is a major impact on relationships, self-esteem, and overall health. RPR contains rich-in growth factors and has the properties of helping tissue regeneration and nerve repair. Its mechanism is to promote the regeneration of blood vessels in the cavernous body of the penis, increase blood circulation, and then help erection, increase penile stiffness and improve the phenomenon of premature ejaculation. The main purpose of this study is to study the safety and effectiveness of PRP injection for the treatment of ED.

Conditions

• Erectile Dysfunction
• PRP

Interventions

Type	Name	Description
BIOLOGICAL	PRP	4\~6ml autologous platelet rich plasma injection every 14±2 days for a total of 5 injections.

Timeline

• Start date: 2021-03-22
• Primary completion: 2022-09-22
• Completion: 2022-11-29
• First posted: 2022-02-16
• Last updated: 2022-02-16

Locations

1 site across 1 country: Taiwan